Featured Research

from universities, journals, and other organizations

New Hope For Deadly Childhood Disease

Date:
December 14, 2007
Source:
University of Rochester Medical Center
Summary:
Investigators have uncovered a promising drug therapy that offers a ray of hope for children with Batten disease -- a rare neurodegenerative disease that strikes seemingly healthy kids, progressively robs them of their abilities to see, reason and move, and ultimately kills them in their young twenties. The study explains how investigators improved the motor skills of feeble mice that model the disease.

Investigators at the University of Rochester Medical Center have uncovered a promising drug therapy that offers a ray of hope for children with Batten disease -- a rare neurodegenerative disease that strikes seemingly healthy kids, progressively robs them of their abilities to see, reason and move, and ultimately kills them in their young twenties.

The study, highlighted in the January edition of Experimental Neurology, explains how investigators improved the motor skills of feeble mice that model the disease, helping them to better their scores on successive coordination tests.

"No treatment currently exists for these kids -- nothing to halt the disease, or even to slow it down," said one of the study's authors, David Pearce, Ph.D., a nationally renowned Batten disease expert and biochemist at the University of Rochester. His team has published more than 50 studies on the disease's basic mechanisms.

"Since deterioration of motor skills is the rule -- in fact, it's one of the primary symptoms in children with the disease -- the idea that these functions might be able to be partially restored or improved is groundbreaking," Pearce said.

Last year, University of Rochester researchers discovered that, in mice with the disease, a set of the brain's receptor cells -- known as the AMPA receptors -- were unusually sensitive to glutamate, a neurotransmitter vital for learning and memory. These 'super-ticklish' receptors were located in the cerebellum, a brain region that plays a hefty role in sensory perception and motor control.

"For us, their abnormal activity made them key suspects in the brain dysfunction and neurological decline associated with the disease," Pearce said.

To test that, researchers administered a drug that partially blocks these receptors and dims their activity.

Impressively, when diseased mice that received the drug, they -- for the first time -- became able to better their scores on successive coordination tests.

And, though they never reached the same level of nimbleness as healthy mice did, they were fierce candidates for the title of "most improved players." Over the course of the testing, they achieved nearly the same degree of improvement in their before and after coordination scores as healthy mice did. In fact, almost second for second.

"It seems we may have corrected some sort of motor learning deficit in the diseased mice," Pearce said.

While optimistic about these findings, Pearce stressed the importance of reminding affected families that this work is preliminary.

"Much research is yet needed," Pearce said. "The prospect of offering this sort of investigational medicine to affected children is still years out."

Still, he is further encouraged that a drug called Talampanel -- very similar to the blocking compound used by his team in Rochester -- is currently in phase II clinical trials for treating epileptic seizures.

Unlike most anticonvulsants, which typically target cells known as NMDA receptors, Talampanel works by partially blocking AMPA receptors.

"This orally active new drug would be an obvious choice for clinical trials with juvenile Batten disease patients," Pearce said. "Especially since they routinely suffer seizures, as well."

Though only 150 children in the United States suffer Batten disease, Pearce is hopeful that this research will also likely also inform research efforts for a dozen or so of its cousins -- other uncommon genetic diseases, each characterized by a glitch with the cell's toxin-ridding mechanisms, the lysosomes.

Some of these lysosomal-storage diseases, as they're called, include Krabbe disease (to which Buffalo Bills quarterback Jim Kelly lost his son, Hunter, in 2005), Tay-Sachs and metchromatic leukodystrophy.

"Our research might indeed open doors for learning how other neurological disorders might benefit from drugs that regulate AMPA receptors," Pearce said.

Co-author Attila Kovács, Ph. D., assistant research professor in the Department of Biochemistry and Biophysics at the University of Rochester, contributed to this investigation, which was funded by National Institutes of Health and the Luke and Rachel Batten Foundation.


Story Source:

The above story is based on materials provided by University of Rochester Medical Center. Note: Materials may be edited for content and length.


Cite This Page:

University of Rochester Medical Center. "New Hope For Deadly Childhood Disease." ScienceDaily. ScienceDaily, 14 December 2007. <www.sciencedaily.com/releases/2007/12/071212201333.htm>.
University of Rochester Medical Center. (2007, December 14). New Hope For Deadly Childhood Disease. ScienceDaily. Retrieved August 27, 2014 from www.sciencedaily.com/releases/2007/12/071212201333.htm
University of Rochester Medical Center. "New Hope For Deadly Childhood Disease." ScienceDaily. www.sciencedaily.com/releases/2007/12/071212201333.htm (accessed August 27, 2014).

Share This




More Health & Medicine News

Wednesday, August 27, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

WHO Calls for Ban on E-Cigarette Sales to Minors

WHO Calls for Ban on E-Cigarette Sales to Minors

AFP (Aug. 26, 2014) — The World Health Organization called Tuesday on governments should ban the sale of e-cigarettes to minors, warning that they pose a "serious threat" to foetuses and young people. Duration: 01:44 Video provided by AFP
Powered by NewsLook.com
Have You Ever Been 'Sleep Drunk?' 1 in 7 Has

Have You Ever Been 'Sleep Drunk?' 1 in 7 Has

Newsy (Aug. 26, 2014) — A study published in the journal "Neurology" interviewed more than 19,000 people and found 15 percent suffer from being "sleep drunk." Video provided by Newsy
Powered by NewsLook.com
Does Medical Marijuana Reduce Painkiller Overdose Deaths?

Does Medical Marijuana Reduce Painkiller Overdose Deaths?

Newsy (Aug. 26, 2014) — A new study found fewer deaths from prescription drug overdoses in states that have legalized medical marijuana. But experts disagree on the results. Video provided by Newsy
Powered by NewsLook.com
Official: British Ebola Sufferer Receiving Experimental Drug

Official: British Ebola Sufferer Receiving Experimental Drug

AFP (Aug. 26, 2014) — A British nurse infected with Ebola while working in Sierra Leone is being given the same experimental drug used on two US missionaries who have recovered for the disease, doctors in London say. Duration: 00:44 Video provided by AFP
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
 
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:  

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

    Environment News

    Technology News



    Save/Print:
    Share:  

    Free Subscriptions


    Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

    Get Social & Mobile


    Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

    Have Feedback?


    Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
    Mobile iPhone Android Web
    Follow Facebook Twitter Google+
    Subscribe RSS Feeds Email Newsletters
    Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins